Viewing Study NCT06537505



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06537505
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-29

Brief Title: A Study of Microwave Ablation Combined With Immunotherapy Anti-angiogenic Drugs in the Treatment of Solid Tumors
Sponsor: None
Organization: None

Study Overview

Official Title: An Exploratory Clinical Study of Microwave Ablation Combined With Immunotherapy Anti-angiogenic Drugs in the Treatment of Advanced Second-line and Above Solid Tumors
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a multi-center phase Il trial to evaluate the efficacy and safety of microwave ablation combined with immunotherapy anti-angiogenic drugs in the treatment of advanced second-line and above solid tumors
Detailed Description: This study plans to recruit 60 patients witha dvanced second-line and above solid tumors observe and evaluate the effectiveness and safety of microwave ablation combined with immunotherapy anti-angiogenic drugs

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None